Education
About Us
Working with TipRanks
Follow Us
PRISM BioLab Co. LTD (JP:206A)
:206A
Total Valuation
PRISM BioLab Co. LTD has a market cap or net worth of ¥7.09B. The enterprise value is ¥3.22B.
Market Cap¥7.09B
Enterprise Value¥3.22B
Share Statistics
PRISM BioLab Co. LTD has 36,934,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,934,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PRISM BioLab Co. LTD’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -28.52%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-28.52%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee25.09M
Profits Per Employee-30.88M
Employee Count27
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PRISM BioLab Co. LTD is ―. PRISM BioLab Co. LTD’s PEG ratio is 0.23.
PE Ratio―
PS Ratio9.06
PB Ratio2.27
Price to Fair Value2.27
Price to FCF-4.00
Price to Operating Cash Flow―
PEG Ratio0.23
Income Statement
In the last 12 months, PRISM BioLab Co. LTD had revenue of 677.33M and earned -833.70M in profits. Earnings per share was -22.82.
Revenue677.33M
Gross Profit269.76M
Operating Income-774.45M
Pretax Income-831.28M
Net Income-833.70M
EBITDA-831.28M
Earnings Per Share (EPS)-22.82
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
PRISM BioLab Co. LTD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-30.10%
50-Day Moving Average174.44
200-Day Moving Average194.56
Relative Strength Index (RSI)66.48
Average Volume (3m)2.26M
Important Dates
PRISM BioLab Co. LTD upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
PRISM BioLab Co. LTD as a current ratio of 8.21, with Debt / Equity ratio of ―
Current Ratio8.21
Quick Ratio8.21
Debt to Market Cap0.00
Net Debt to EBITDA3.51
Interest Coverage Ratio0.00
Taxes
In the past 12 months, PRISM BioLab Co. LTD has paid 2.42M in taxes.
Income Tax2.42M
Effective Tax Rate>-0.01
Enterprise Valuation
PRISM BioLab Co. LTD EV to EBITDA ratio is -3.88, with an EV/FCF ratio of -2.10.
EV to Sales4.76
EV to EBITDA-3.88
EV to Free Cash Flow-2.10
EV to Operating Cash Flow-2.19
Balance Sheet
PRISM BioLab Co. LTD has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share¥74.15
Margins
Gross margin is ―, with operating margin of -114.34%, and net profit margin of -123.09%.
Gross Margin―
Operating Margin-114.34%
Pretax Margin-122.73%
Net Profit Margin-123.09%
EBITDA Margin-122.73%
EBIT Margin-122.73%
Analyst Forecast
The average price target for PRISM BioLab Co. LTD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―